A Randomized Phase 2/3 Study of Olaparib Plus Temozolomide Versus Investigator's Choice for the Treatment of Patients with Advanced Uterine Leiomyosarcoma After Progression on Prior Chemotherapy

Protocol No
ALLIANCE-A092104
Phase
II/III
Summary

Is the combination of olaparib and temozolomide better than the usual treatment for advanced
uterine leiomyosarcoma after initial chemotherapy has stopped working?

Description
Testing olaparib and temozolomide versus the usual treatment for uterine leiomyosarcoma after chemotherapy has stopped working
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL